Brief: Orphazyme A/S Sees 2023 Operating Loss In Range Of Dkk 30 - 35 Mln
April 25 (Reuters) - Orphazyme A/S ORPHA.CO :
* SEES 2023 OPERATING LOSS IN RANGE OF DKK 30 - 35 MILLION
* FY 2022 LOSS FROM CONTINUING OPERATIONS WAS DKK 38.3
MILLION
Source text for Eikon: ID:nGNE9JJk0V
Further company coverage: ORPHA.CO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Strategic Partners A/S
See all newsBrief: Strategic Partners Reports H1 EBIT Loss Of DKK 1.0 Mln, Maintains FY Guidance
Brief: Strategic Partners Buys Three Retail Properties In Tilst
Brief: Strategic Partners Q1 EBIT Loss At DKK 0.6 Mln
Brief: Strategic Partners Buys DKK 3 Mln Of Shares In Gyldendal
Brief: Strategic Partners 9-month EBIT Loss DKK 1.7 Mln